GW PHARMACEUTICALS LIMITED

Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  —

  Not reported

• Net assets

  -9%

  £1,025,780,070 → £933,147,940

• Employees

  —

  Not reported

• Operating profit

  -314.1%

  -£276,594 → -£1,145,249

• Profit before tax

  +17,393.9%

  -£424,609 → £73,431,263

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. GW PHARMACEUTICALS LIMITED 2021-06-04 → present
2. GW PHARMACEUTICALS PLC 2001-06-01 → 2021-06-04
3. GW PHARMACEUTICALS GROUP PLC 2001-03-06 → 2001-06-01
4. MAWLAW 541 PLC 2001-02-15 → 2001-03-06

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

KPMG

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Directors having made enquiries believe that the Company has adequate resources to continue in operational existence for a period of 12 months from the date of approval and that it is appropriate to continue to adopt the going concern basis in preparing the financial statements.”

Group structure

1. GW PHARMACEUTICALS LIMITED · parent
   1. Jazz Pharmaceuticals Operations UK Limited 100% · Production and commercial
   2. Jazz Pharmaceuticals Research UK Ltd 100% · Research and development
   3. Jazz Financing UK Limited 100% · Commercial
   4. GW UK Services Ltd 100% · Commercial
   5. GWP Trustee Company Ltd 100% · Dissolved
   6. Jazz Pharmaceuticals Japan K.K 100% · Commercial

Significant events

• “During the year ended 31 December 2024 one indirectly-owned subsidiary of the Company, GW UK Services Ltd, agreed to transfer the trade to another Group Company, Jazz Pharmaceuticals UK Limited, as part of a Business Transfer Agreement.”
• “One directly-owned subsidiary, GW Global Services and two indirectly-owned subsidiary, GWP Trustee Company Ltd and GWP Trustee Company Ltd, dissolved during the year ended 31 December 2024.”
• “In addition, there was a reduction in the shareholder's equity in one directly-owned subsidiary of the Company, Jazz Pharmaceuticals Operations UK Limited.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.